文档介绍：医改论坛
2010 年第 4 期 Forum on Medical Reform
我国药品集中招标采购
存在的制度缺陷
于培明 1 宋丽丽 2 岳淑梅 2
摘要:目的:剖析我国药品集中招标采购存在的制度缺陷,提出政策建议。方法:对我国公立医院
药品采购模式发展脉络进行梳理,得出结论。结果与结论:我国药品集中招标采购的制度设计和实
际做法表现出剥夺公立医院药品采购权的倾向,但剥夺不彻底,使得公立医院仍保留着相当的控制力,
并阻碍政策目标的实现。必须对公立医院的药品采购实行彻底的政府采购,彻底取消公立医院对药
品采购销售的控制,才能实现药品集中招标采购的政策目标。
关键词:药品招标采购政府采购制度缺陷
[Abstract] Objective: Analyze defects of centralized bidding system of drug purchase for public
hospitals and make proposals. Methods: by sorting out the development of centralized bidding
system of drug purchase for public hospitals. Results and Conclusions: The design and practice
of centralized bidding system of drug purchase tend to deprive public hospitals of the power over
drug purchase. But the present system does not get to the core. Public hospitals still get control
over drug purchase. And this makes the policy of centralized bidding system fail. In order to solve
the problem we should change the present system to government procurement. Only in this way
will the problem be solved.
[Key Words] Drugs; Bidding procurement; Government procurement; System defects
医疗机构实施药品招标采购制度以前,我国方药品招标采购实践的基础上,国家于 2000 年
药品价格的 70% 消耗在流通环节[1]。相伴而生的开始在全国进行药品集中招标采购试点,公立医
是药价虚高,商业贿赂现象严重。在这样的背景下, 院药品集中招标采购的序幕由此拉开。资料显示,
中国药物经济学
一些地方开始了药品招标采购的探索。在总结地药品集中招标采购之初(2000 ~ 2002 年), 医疗
1 于培明,药事管理学博士,副教授,研究方向为国家药物政策与法;河南大学药学院,河南开封 475004
2 宋丽丽,岳淑梅,河南大学